ZNTL
Zentalis Pharmaceuticals Llc
2.70$
-4.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.0% | -0.8% | -11.8% | -8.3% | -4.5% | -10.8% | -8.4% | -7.0% | -11.7% | -12.4% | -14.9% | |
| – | -6.0% | +1.4% | -12.7% | -9.0% | -3.5% | -11.2% | -9.1% | -7.5% | -12.2% | -13.9% | -16.9% | |
| – | -74.7% | +34.2% | -1.7% | +11.7% | -18.0% | +23.7% | -10.3% | +3.9% | -7.9% | -11.3% | -22.4% | |
| – | -6.5% | +1.3% | -12.8% | -8.2% | -5.2% | -10.4% | -8.7% | -7.5% | -12.4% | -13.9% | -17.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | |
| – | +20.1% | -20.8% | +10.5% | -11.7% | -3.3% | -4.8% | -12.9% | -3.7% | -2.2% | -3.3% | +1.8% | |
| – | +17.7% | -21.0% | +21.7% | -17.7% | -3.9% | -6.2% | -21.1% | -4.8% | -1.6% | -3.6% | +6.8% | |
| – | +8.2% | +4.4% | -1.1% | +3.7% | +9.4% | +14.2% | +3.4% | +3.4% | +3.3% | +3.3% | +3.3% | |
| – | +4.6% | -29.6% | +94.6% | -59.9% | -9.3% | +4.5% | -52.1% | +89.1% | +2.5% | +2.4% | +10.4% | |
| – | -9.2% | +4.9% | -16.6% | -7.4% | -4.8% | -12.4% | -7.1% | -7.9% | -14.5% | -15.5% | -21.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.6% | -0.2% | +0.1% | +0.2% | +0.6% | +0.4% | +0.2% | -0.6% | -2.0% | +0.0% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.